The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full solvency assessment. Despite strong year-over-year earnings growth and solid operating margins, the company is unprofitable on net (negative profit margin and ROE), carries a high debt/equity ratio of 1.52, and shows poor liquidity with current and quick ratios below 1.0. Valuation metrics are stretched, with a negative forward P/E and a Price/Book of 4.80, while insider activity is decisively bearish, with recent selling by major shareholders. The stock has underperformed recently, down 13.4% over six months, and lacks analyst coverage, increasing uncertainty.